Back to Search
CALEB FARLEY, PHD
PHD
Counselor
NPI: 1396585113Individual
Specialties, Licenses & Credentials
CounselorPrimary
Counselor
Code: 101Y00000X
Research & Publications (20)
Meal pattern analysis of diet-induced obesity in susceptible and resistant rats.
PMID 12855753·Obes Res·2003
7-preclinical
Robust passive dynamics of the musculoskeletal system compensate for unexpected surface changes during human hopping.
PMID 19589956·J Appl Physiol (1985)·2009
8-other
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.
PMID 19299236·Clin Breast Cancer·2009
3-trial
Effects of aging and arm swing on the metabolic cost of stability in human walking.
PMID 18814873·J Biomech·2008
8-other
Postnatal manganese exposure alters dopamine transporter function in adult rats: Potential impact on nonassociative and associative processes.
PMID 18485605·Neuroscience·2008
7-preclinical
A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.
PMID 18650154·Clin Breast Cancer·2008
3-trial
Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
PMID 18543319·Cancer·2008
3-trial
Discovery of novel orally active ureido NPY Y5 receptor antagonists.
PMID 18160282·Bioorg Med Chem Lett·2008
7-preclinical
Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network.
PMID 17470864·J Clin Oncol·2007
3-trial
Individual limb work does not explain the greater metabolic cost of walking in elderly adults.
PMID 17363623·J Appl Physiol (1985)·2007
8-other
Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial.
PMID 18272024·Clin Genitourin Cancer·2007
3-trial
Time from ictal subdural EEG seizure onset to clinical seizure onset: an electrocorticographic time factor associated with temporal lobe epileptogenicity.
PMID 17601365·Neurol Res·2007
3-trial
Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network.
PMID 17823908·Cancer·2007
3-trial
Effects of early methylphenidate exposure on morphine- and sucrose-reinforced behaviors in adult rats: relationship to dopamine D2 receptors.
PMID 17274963·Brain Res·2007
7-preclinical
Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
PMID 16570926·J Med Chem·2006
7-preclinical
The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen.
PMID 16447063·Psychopharmacology (Berl)·2006
7-preclinical
Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
PMID 16540104·Eur J Pharmacol·2006
7-preclinical
Human hoppers compensate for simultaneous changes in surface compression and damping.
PMID 16549093·J Biomech·2006
8-other
Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: longevity of agonistic effects.
PMID 17070785·Brain Res·2006
4-observational
Parameterization of the shape of intracranial saccular aneurysms using Legendre polynomials.
PMID 16154873·Comput Methods Biomech Biomed Engin·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 13460 WALSH DR
BOYS TOWN, NE 68010 - Phone
- (531) 355-3358
Quick Facts
- NPI
- 1396585113
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile